Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
BioConferenceLive

Non-DEHP and Phthalate-Free Tubing Now Available for Routine Laboratory Applications

By BiotechDaily International staff writers
Posted on 27 Aug 2013
A major European manufacturer of high-performance flexible tubing and other plastic laboratory products has introduced a bio-based, phthalate-free product for use in routine laboratory applications.

Saint-Gobain Performance Plastics (Paris, France) the manufacturer of Tygon high-performance flexible tubing, has recently introduced a bio-based, phthalate-free product. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon formulations.

The next-generation DEHP- and phthalate-free Tygon S3 tubing is made with a bio-based plasticizer and the product’s new sustainable formulations are biodegradable and deliver superior pump life. For example, Tygon S3 E-3603 non-DEHP tubing was specially formulated for resistance to flex-fatigue and abrasion. In many peristaltic pump applications, it outlasts the original R-3603 by a factor of three to one. As tubing for an instrumentation connection, vent, drain and other general laboratory applications, Tygon S3 E-3603 Tubing offers superior life, which minimizes the labor and expense of replacement.

New Tygon S3 formulations include Tygon S3 E-3603 General Laboratory Tubing and Tygon S3 E-LFL Long Flexible Life Tubing. Tygon R-1000 has also been replaced by Tygon E-1000, soft and flexible non-DEHP tubing.

“The change to non-DEHP tubing is integral to the company’s continued efforts toward safety, compliance, and sustainability,” said Katia May, laboratory market manager for Saint-Gobain Performance Plastics. “Saint-Gobain is the first manufacturer to remove DEHP and phthalates from tubing products for laboratory applications and beyond. We are committed to providing superior, smart, safe, and sustainable flexible tubing with unsurpassed performance.”

Related Links:

Saint-Gobain


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.